Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancerA Tognoni, L Cadenotti, F Pensa, et al.
Oncology|January 1, 1989
The role of surgery in the combined treatment of locally advanced breast cancerG Canavese, A Catturich, G Battistini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimideL Repetto, P Pronzato, A Ardizzoni, et al.
Oncology|June 26, 2004
Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational studyM Cazzaniga, P Pronzato, S L Leto di Priolo, et al.
American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized studyP F Conte, A Rubagotti, A Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized cooperative study of perioperative chemotherapy in breast cancerM R Sertoli, P Bruzzi, P Pronzato, et al.
Breast Cancer Research and Treatment|August 10, 2000
Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorinA Venturino, D Comandini, C Simoni, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancerA Tognoni, L Cadenotti, F Pensa, et al.
Oncology|January 1, 1989
The role of surgery in the combined treatment of locally advanced breast cancerG Canavese, A Catturich, G Battistini, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1987
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimideL Repetto, P Pronzato, A Ardizzoni, et al.
Oncology|June 26, 2004
Patterns of relapse and modalities of treatment of breast cancer: the 'IRIS' Project, a multicenter observational studyM Cazzaniga, P Pronzato, S L Leto di Priolo, et al.
American Journal of Clinical Oncology|December 1, 1993
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuationP Pronzato, A Rubagotti, D Amoroso, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized studyP F Conte, A Rubagotti, A Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized cooperative study of perioperative chemotherapy in breast cancerM R Sertoli, P Bruzzi, P Pronzato, et al.
Breast Cancer Research and Treatment|August 10, 2000
Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorinA Venturino, D Comandini, C Simoni, et al.
Pageof 13